Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer.
Marks DK, Gartrell RD, El Asmar M, Boboila S, Hart T, Lu Y, Pan Q, Yu J, Hibshoosh H, Guo H, Andreopoulou E, Wiechmann L, Crew K, Sparano J, Hershman D, Connolly E, Saenger Y, Kalinsky K. Marks DK, et al. Among authors: lu y. Front Oncol. 2020 Jun 16;10:968. doi: 10.3389/fonc.2020.00968. eCollection 2020. Front Oncol. 2020. PMID: 32612958 Free PMC article.
Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin.
Marks DK, Kucharczyk J, Kim P, Chyong DI, Gartrell RD, Lu Y, Hibshoosh H, Guo H, Evans TRJ, Lopez J, Kristeleit R, Connolly E, Saenger Y, Kalinsky K. Marks DK, et al. Among authors: lu y. Cancer Invest. 2021 Jul-Aug;39(6-7):466-472. doi: 10.1080/07357907.2021.1938109. Epub 2021 Jun 21. Cancer Invest. 2021. PMID: 34075851
Quantitative Analysis of Immune Infiltrates in Primary Melanoma.
Gartrell RD, Marks DK, Hart TD, Li G, Davari DR, Wu A, Blake Z, Lu Y, Askin KN, Monod A, Esancy CL, Stack EC, Jia DT, Armenta PM, Fu Y, Izaki D, Taback B, Rabadan R, Kaufman HL, Drake CG, Horst BA, Saenger YM. Gartrell RD, et al. Among authors: lu y. Cancer Immunol Res. 2018 Apr;6(4):481-493. doi: 10.1158/2326-6066.CIR-17-0360. Epub 2018 Feb 21. Cancer Immunol Res. 2018. PMID: 29467127 Free PMC article.
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer.
Hershman DL, Richards CA, Kalinsky K, Wilde ET, Lu YS, Ascherman JA, Neugut AI, Wright JD. Hershman DL, et al. Among authors: lu ys. Breast Cancer Res Treat. 2012 Nov;136(2):535-45. doi: 10.1007/s10549-012-2273-4. Epub 2012 Sep 29. Breast Cancer Res Treat. 2012. PMID: 23053659 Free PMC article.
Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.
Reiniger N, Lau K, McCalla D, Eby B, Cheng B, Lu Y, Qu W, Quadri N, Ananthakrishnan R, Furmansky M, Rosario R, Song F, Rai V, Weinberg A, Friedman R, Ramasamy R, D'Agati V, Schmidt AM. Reiniger N, et al. Among authors: lu y. Diabetes. 2010 Aug;59(8):2043-54. doi: 10.2337/db09-1766. Epub 2010 Jul 13. Diabetes. 2010. PMID: 20627935 Free PMC article.
Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, Lerner S, Bakr S, Li Q, Lu Y, Song F, Qu W, Gomez T, Zou YS, Yan SF, Schmidt AM, Ramasamy R. Bucciarelli LG, et al. Among authors: lu y. Circulation. 2006 Mar 7;113(9):1226-34. doi: 10.1161/CIRCULATIONAHA.105.575993. Epub 2006 Feb 27. Circulation. 2006. PMID: 16505177
47,882 results
You have reached the last available page of results. Please see the User Guide for more information.